MOORESTOWN, N.J., May 08, 2017 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, today announced that Chief Financial Officer, Brian Adams, will participate in the 2017 UBS Global Healthcare Conference in New York.
Mr. Adams is scheduled to present at the conference on Tuesday, May 23, 2017 at 3:30 p.m. ET. A live audio-only webcast of the presentation will be available on the investor relations section of the Company’s website at ir.trhc.com. The archived webcast and presentation materials will also be available for 90 days at the same URL.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, please visit: www.TRHC.com.
Contact: Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 [email protected] Media Dianne Semingson 215-870-0829 [email protected]


U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips 



